These post-translational modifications and feedback mechanisms collectively ensure that NF-κB activity is tightly controlled to prevent excessive or prolonged activation, thereby reducing the risk of chronic inflammation, autoimmune disorders, and cancer. This evidence concerns the gene NFKB1 and autoimmune disease.